HER2-negative

Open Access
First-line immunotherapy for advanced HER2-negative gastric cancer: differences between Asian and non-Asian patients
Chuanhua Zhao, Sisi Ye, Meng Chen, Jing Qian and Jianming Xu

Cancer Biology & Medicine February 2026, 23 (2) 201-217; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0398
You have access
Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan

Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463

Main menu